|
pubmed:abstractText |
We previously suggested that biochemical alterations of peritoneal membrane associated with long-term peritoneal dialysis might be, at least in part, accounted for by reactive carbonyl compounds overload originating both from uremic circulation and heat sterilization of glucose peritoneal dialysis fluid. In the present study, we utilized a uremic rat model on peritoneal dialysis and evaluated the protective effects of pyridoxamine, a recently developed inhibitor of advanced glycation end product (AGE), on structural, functional, and biochemical alterations of peritoneal membrane.
|
|
pubmed:affiliation |
Department of Internal Medicine and Institute of Medical Science, Tokai University School of Medicine, Isehara, Kanagawa, Japan. kakuta@is.icc.u-tokai.ac.jp
|
